Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of an oral testosterone
undecanoate formulation for use as testosterone-replacement therapy in men with low
testosterone.